NVCR Q1 2020 Earnings — NovoCure Limited Revenue & Financial Results | Market Cap Arena

NVCRNovoCure Limited

$1B

Q1 2020 Earnings

Healthcare Medical - Instruments & Supplies

Income Statement

Revenue

$102M+38.9% YoY

Gross Profit

$77M75.9% margin

Operating Income

-$3M-3.3% margin

Net Income

$4M3.9% margin

EPS (Diluted)

$0.04

QoQ Revenue Growth

+2.6%

Cash Flow

Operating Cash Flow

$2M

Free Cash Flow

-$1M

Stock-Based Comp.

$17M

Balance Sheet

Total Assets

$502M

Total Liabilities

$261M

Stockholders' Equity

$242M

Cash & Equivalents

$182M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$102M	$73M	+38.9%
Gross Profit	$77M	$53M	+44.6%
Operating Income	-$3M	-$6M	+44.7%
Net Income	$4M	-$12M	+132.5%

Geographic Segments

UNITED STATES

$69M68%

GERMANY

$22M21%

JAPAN

$6M6%

EMEA, Exculding Germany

$3M3%

CHINA

$2M2%